Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Men had worse COVID-19 outcomes than women in New York City.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

Skin symptoms appear in up to 20% of Covid-19 cases.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

Older age and existing health issues increase COVID-19 death risk.

Genetic differences affect COVID-19 severity and treatment effectiveness.

PCOS women with COVID-19 have higher cardiometabolic risks.

Balancing testosterone may reduce COVID-19 severity.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Older age and existing health conditions increase COVID-19 death risk.

Insulin resistance linked to obesity may increase COVID-19 severity.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Collider bias can distort our understanding of COVID-19 risk and severity.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.